A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis Clinical Trial

Official title:
A Prospective, Randomized, Controlled, Multicenter, Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

Status Completed

Clinical Trial Summary

This study will explore the use of OP-1 Putty in conjunction with surgical treatment for the treatment of spinal decompression and lumbar spinal fusion.

Clinical Trial Description

It is postulated that the addition of OP-1 Putty to autogenous bone will prove beneficial in the treatment of patients requiring decompression and lumbar spinal fusion. The Investigational system is intended to stimulate bone growth. It is indicated as an adjunct or a replacement for autograft in spinal fusion. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Degenerative Lumbar Spondylolisthesis
Spondylolisthesis

Clinical Trial Details

NCT number	NCT00679107
Study type	Interventional
Source	Olympus Biotech Corporation
Contact
Status	Completed
Phase	N/A
Start date	June 1999
Completion date	July 2005

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06407063` - Long-term Reoperations After Lumbar Spinal Stenosis Surgery
Active, not recruiting	`NCT03469791` - Degenerative Spondylolisthesis; Micro-decompression vs Decompression + Instrumented Fusion; Long Term Follow up	N/A
Completed	`NCT00677950` - OP-1 Putty for Posterolateral Fusions	N/A
Recruiting	`NCT05961956` - Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis	Phase 1/Phase 2
Completed	`NCT00678353` - Study of OP-1 Putty in Uninstrumented Posterolateral Fusions	N/A
Recruiting	`NCT02290314` - Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion	N/A